Clinical Trials Browser

Has results × Virus Diseases × Papillomavirus Vaccines × Clear all

NCT00541970 2018-08-17

Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs

Phase 1 Completed

961 enrolled 43 charts

Uterine Cervical Neoplasms, Virus Diseases, Papillomavirus Infections